Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
CJM112 is a novel Interleukin-17A (IL-17A) receptor antagonists. It functions by binding to both IL-17A and IL-17AF, which are cytokines involved in inflammatory processes.
…